[HTML][HTML] Application of green gold nanoparticles in cancer therapy and diagnosis
Nanoparticles are currently used for cancer theranostics in the clinical field. Among
nanoparticles, gold nanoparticles (AuNPs) attract much attention due to their usability and …
nanoparticles, gold nanoparticles (AuNPs) attract much attention due to their usability and …
Mature and immature ovarian teratomas: CT, US and MR imaging characteristics
L Saba, S Guerriero, R Sulcis, B Virgilio… - European journal of …, 2009 - Elsevier
Ovarian teratomas (OTs) are the most common germ cell neoplasm. They include mature
cystic teratomas, monodermal teratomas (neural tumors, struma ovarii, carcinoid tumors) …
cystic teratomas, monodermal teratomas (neural tumors, struma ovarii, carcinoid tumors) …
[PDF][PDF] Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with …
BE Hillner, BA Siegel, D Liu, AF Shields… - Journal of Clinical …, 2008 - Citeseer
Purpose Under Medicare's Coverage with Evidence Development policy, positron emission
tomography (PET)/computed tomography (CT) and PET became covered services for …
tomography (PET)/computed tomography (CT) and PET became covered services for …
18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis
EE Pakos, AD Fotopoulos… - Journal of Nuclear …, 2005 - Soc Nuclear Med
The ability of PET with 18F-FDG to evaluate bone marrow infiltration in patients with
lymphoma has been a matter of extensive investigation with controversial results. Therefore …
lymphoma has been a matter of extensive investigation with controversial results. Therefore …
Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection
E Even-Sapir, Y Parag, H Lerman, M Gutman, C Levine… - Radiology, 2004 - pubs.rsna.org
PURPOSE: To assess diagnostic accuracy of combined positron emission tomography
(PET) and computed tomography (CT) in detection of pelvic recurrence in patients with rectal …
(PET) and computed tomography (CT) in detection of pelvic recurrence in patients with rectal …
[HTML][HTML] Molecular imaging for personalized cancer care
MF Kircher, H Hricak, SM Larson - Molecular oncology, 2012 - Elsevier
Molecular imaging is rapidly gaining recognition as a tool with the capacity to improve every
facet of cancer care. Molecular imaging in oncology can be defined as in vivo …
facet of cancer care. Molecular imaging in oncology can be defined as in vivo …
Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: histopathologic comparison
H Agress Jr, BZ Cooper - Radiology, 2004 - pubs.rsna.org
PURPOSE: To determine the clinical importance and malignant potential of unexpected
abnormal foci of hypermetabolism at fluorodeoxyglucose (FDG) positron emission …
abnormal foci of hypermetabolism at fluorodeoxyglucose (FDG) positron emission …
Use of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA: a systematic review and meta-analysis
Aim The purpose of the present study was to conduct a systematic review and meta-analysis
of the published literature to assess the diagnostic performance of FDG-PET or PET/CT in …
of the published literature to assess the diagnostic performance of FDG-PET or PET/CT in …
Positron emission tomography in oncology: a review
KA Wood, PJ Hoskin, MI Saunders - Clinical Oncology, 2007 - Elsevier
Positron emission tomography is an evolving imaging tool that is becoming increasingly
available for use in clinical practice. This overview will look at the current evidence for the …
available for use in clinical practice. This overview will look at the current evidence for the …
Early Detection of Tumor Response to Chemotherapy by 3′-Deoxy-3′-[18F]Fluorothymidine Positron Emission Tomography: The Effect of Cisplatin on a Fibrosarcoma Tumor …
J Leyton, JR Latigo, M Perumal, H Dhaliwal, Q He… - Cancer research, 2005 - AACR
We have assessed the potential of [18F] fluorothymidine positron emission tomography
([18F] FLT-PET) to measure early cytostasis and cytotoxicity induced by cisplatin treatment of …
([18F] FLT-PET) to measure early cytostasis and cytotoxicity induced by cisplatin treatment of …